{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:38:41Z","timestamp":1785515921589,"version":"3.56.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The associated symptoms of hypogonadism have been reported in patients with various types of cancer. However, the prevalence and significance of hypogonadism among certain hematologic malignancies have not been completely summarized in recent literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>In this review we aimed to examine the current literature on hypogonadism in patients with hematologic malignancies, with emphasis on leukemias, lymphomas, and multiple myeloma (MM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This review included relevant studies published before July 2023 that were retrieved through a search of PubMed using the keywords \u201chematologic cancer,\u201d \u201chematologic malignancy,\u201d blood cancer,\u201d \u201cleukemia,\u201d \u201clymphoma,\u201d \u201chypogonadism,\u201d \u201cmultiple myeloma,\u201d and \u201ctestosterone.\u201d<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The search yielded 214 studies, of which 21 met the inclusion criteria. Commonly reported findings were that patients who had received hematopoietic stem cell therapy for acute lymphoblastic leukemia and acute myelogenous leukemia as children had laboratory-confirmed hypogonadism as adults. However, the impact of these diseases on hypogonadal symptoms was variable in these studies.<\/jats:p>\n                  <jats:p>Studies reporting on lymphoma and hypogonadism had mixed results, with some studies finding that the degree of cytotoxic chemotherapy was associated with hypogonadism, while others showed no correlation. Regardless, multiple studies found that hypogonadism secondary to lymphoma treatment and symptoms of hypogonadism had no apparent association.<\/jats:p>\n                  <jats:p>The most comprehensive assessment of the frequency of hypogonadism in an MM cohort found that 74% of 561 MM patients were classified as hypogonadal compared to 33% of patients in a control population. Testosterone supplementation was found to lower interleukin-6 levels, which could potentially help manage some of the adverse effects of MM, including decreased bone mineral density.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>There is a relationship between hematologic malignancies and hypogonadism, which is likely multifactorial. In this review we established that the most plausible factors are related to the secondary effects of gonadotoxic treatments and\/or systemic inflammatory responses to the diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sxmrev\/qeae017","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T20:44:47Z","timestamp":1708980287000},"page":"449-457","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between hematologic malignancies on male hypogonadism: a scoping review"],"prefix":"10.1093","volume":"12","author":[{"given":"Bradley","family":"Roth","sequence":"first","affiliation":[{"name":"Department of Urology, University of California , Irvine, Irvine 92697, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed A","family":"Moukhtar Hammad","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California , Irvine, Irvine 92697, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I","family":"Sanford","sequence":"additional","affiliation":[{"name":"Department of Urology, Brown University , Providence 02905, RI, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Piper","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine , Hershey 17033, PA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Barham","sequence":"additional","affiliation":[{"name":"Brooke Army Medical Center AHP, Fort Sam Houston , San Antonio 78234, TX, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal A","family":"Yafi","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California , Irvine, Irvine 92697, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California , Irvine, Irvine 92697, CA, United States"},{"name":"Tulane University, Department of Urology, New Orleans, New Orleans 70112, LA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"1","key":"2024070101014188400_ref1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"issue":"5","key":"2024070101014188400_ref2","first-page":"1","article-title":"Epidemiology of hematologic malignancies in real-world settings: findings from the Hemato-oncology Latin America observational registry study","volume":"5","author":"de Moraes","year":"2019","journal-title":"J Glob Oncol"},{"issue":"8","key":"2024070101014188400_ref3","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41375-021-01134-3","article-title":"Late outcomes in survivors of childhood acute myeloid leukemia: a report from the St. Jude lifetime cohort study","volume":"35","author":"Bhatt","year":"2021","journal-title":"Leukemia"},{"issue":"6","key":"2024070101014188400_ref4","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/S2352-3026(19)30050-X","article-title":"The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude lifetime cohort study","volume":"6","author":"Mulrooney","year":"2019","journal-title":"Lancet Haematol"},{"issue":"2","key":"2024070101014188400_ref5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and Management of Testosterone Deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"issue":"3","key":"2024070101014188400_ref6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive health\u20142021 update: male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"issue":"5","key":"2024070101014188400_ref7","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024070101014188400_ref8","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/cncr.21889","article-title":"Hypogonadism in male patients with cancer","volume":"106","author":"Garcia","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"2024070101014188400_ref9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/cncr.28619","article-title":"Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer","volume":"120","author":"Dev","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"2024070101014188400_ref10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000450652","article-title":"Prevalence of late-onset hypogonadism in men with localized and metastatic renal cell carcinoma","volume":"98","author":"Ralla","year":"2017","journal-title":"Urol Int"},{"issue":"4","key":"2024070101014188400_ref11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.urology.2009.03.051","article-title":"Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy","volume":"74","author":"Lackner","year":"2009","journal-title":"Urology"},{"issue":"5","key":"2024070101014188400_ref12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/iju.13537","article-title":"High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors","volume":"25","author":"Kurobe","year":"2018","journal-title":"Int J Urol"},{"issue":"3","key":"2024070101014188400_ref13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.sxmr.2017.12.007","article-title":"Urological survivorship issues among adolescent boys and young men who are cancer survivors","volume":"6","author":"Sukhu","year":"2018","journal-title":"Sex Med Rev"},{"issue":"6","key":"2024070101014188400_ref14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jsxm.2016.03.367","article-title":"Erectile dysfunction in male survivors of childhood cancer-a report from the childhood cancer survivor study","volume":"13","author":"Ritenour","year":"2016","journal-title":"J Sex Med"},{"issue":"7","key":"2024070101014188400_ref15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/bmt.2014.63","article-title":"Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma","volume":"49","author":"Greenfield","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2024070101014188400_ref16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jpainsymman.2009.06.014","article-title":"The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report","volume":"39","author":"Fadul","year":"2010","journal-title":"J Pain Symptom Manag"},{"issue":"15","key":"2024070101014188400_ref17","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"2024070101014188400_ref18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpainsymman.2009.09.021","article-title":"Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report","volume":"39","author":"Del Fabbro","year":"2010","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"2024070101014188400_ref19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12672-018-0351-8","article-title":"Aggressiveness of localized prostate cancer: the key value of testosterone deficiency evaluated by both Total and bioavailable testosterone: AndroCan study results","volume":"10","author":"Neuzillet","year":"2019","journal-title":"Horm Cancer"},{"key":"2024070101014188400_ref20","doi-asserted-by":"crossref","first-page":"111407","DOI":"10.1016\/j.exger.2021.111407","article-title":"Relationship between inflammatory biomarkers and testosterone levels in male master athletes and non-athletes","volume":"151","author":"Barbosa","year":"2021","journal-title":"Exp Gerontol"},{"issue":"3","key":"2024070101014188400_ref21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13685530802317934","article-title":"Hypogonadotrophic hypogonadism in type 2 diabetes","volume":"11","author":"Dandona","year":"2008","journal-title":"Aging Male"},{"key":"2024070101014188400_ref22","first-page":"1149","article-title":"Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA\/delA endothelin-1 gene polymorphism. A case-control study","volume":"15(10)","author":"Kaparianos","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2024070101014188400_ref23","first-page":"1","article-title":"Late complications in acute Leukemia patients following HSCT: a single center experience","volume":"10","author":"Vaezi","year":"2016","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"4","key":"2024070101014188400_ref24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/pbc.22518","article-title":"Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy","volume":"55","author":"Geenen","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2024070101014188400_ref25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000431092","article-title":"Increased body adiposity and serum leptin concentrations in very long-term adult male survivors of childhood acute lymphoblastic Leukemia","volume":"84","author":"Jahnukainen","year":"2015","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2024070101014188400_ref26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","article-title":"Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin study group HD13 to HD15 trials","volume":"31","author":"Behringer","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"2024070101014188400_ref27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjc.6604892","article-title":"Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy","volume":"100","author":"Kiserud","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"2024070101014188400_ref28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pbc.23363","article-title":"Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study","volume":"59","author":"Hamre","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"2024070101014188400_ref29","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1210\/jc.2009-0337","article-title":"Hypogonadism risk in men treated for childhood cancer","volume":"94","author":"Romerius","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024070101014188400_ref30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/0284186X.2014.948057","article-title":"Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism","volume":"54","author":"Kiserud","year":"2015","journal-title":"Acta Oncol"},{"issue":"35","key":"2024070101014188400_ref31","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1200\/JCO.2009.23.2280","article-title":"Do male lymphoma survivors have impaired sexual function?","volume":"27","author":"Kiserud","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"2024070101014188400_ref32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2004-12-4689","article-title":"High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver","volume":"106","author":"Lavoie","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2024070101014188400_ref33","first-page":"58","article-title":"Hormonal changes after R-CHOP chemotherapy in patients with diffuse large B-cell lymphoma: a prospective study","volume":"58","author":"Manosroi","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"2024070101014188400_ref34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/10428194.2018.1508664","article-title":"Most multiple myeloma patients have low testosterone","volume":"60","author":"John","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2024070101014188400_ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01741093","article-title":"Sex hormones and immune dysregulation in multiple myeloma","volume":"36","author":"Everaus","year":"1993","journal-title":"Cancer Immunol Immunother"},{"issue":"nov21 1","key":"2024070101014188400_ref36","doi-asserted-by":"crossref","first-page":"bcr0320126050","DOI":"10.1136\/bcr-03-2012-6050","article-title":"Metastatic haematological malignancy presenting as a sellar mass","volume":"2012","author":"Udiawar","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"3","key":"2024070101014188400_ref37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4103\/0973-1482.172123","article-title":"An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: case report and review of literature","volume":"14","author":"Pulivarthi","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"2024070101014188400_ref38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.survophthal.2012.12.005","article-title":"Muscle cramping over the diagnosis","volume":"59","author":"Lally","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"2024070101014188400_ref39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbmt.2019.10.002","article-title":"Survivorship after autologous hematopoietic cell transplantation for lymphoma and multiple myeloma: late effects and quality of life","volume":"26","author":"Georges","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2024070101014188400_ref40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/andr.13117","article-title":"Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men","volume":"10","author":"Anderson","year":"2022","journal-title":"Andrology"},{"issue":"9212","key":"2024070101014188400_ref41","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(00)02121-8","article-title":"Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myeloma","volume":"355","author":"Chatterjee","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"2024070101014188400_ref42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1701342","article-title":"Patterns of gonadal dysfunction following bone marrow transplantation","volume":"22","author":"Mertens","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2024070101014188400_ref43","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-023-00838-8","article-title":"The effect of red blood cell disorders on male fertility and reproductive health","author":"Naelitz","year":"2024  3","journal-title":"Nat Rev Urol"},{"issue":"2","key":"2024070101014188400_ref44","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac183","article-title":"Endocrine sequelae in 157 pediatric survivors of hematopoietic stem cell transplantation (HSCT)","volume":"7","author":"G\u00fcemes","year":"2022","journal-title":"J Endocr Soc"},{"issue":"9","key":"2024070101014188400_ref45","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.bbmt.2020.05.009","article-title":"Male gonadal function after allogeneic hematopoietic stem cell transplantation in childhood: a cross-sectional, population-based study","volume":"26","author":"Mathiesen","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024070101014188400_ref46","doi-asserted-by":"crossref","first-page":"282147","DOI":"10.1155\/2014\/282147","article-title":"Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells","volume":"2014","author":"Orio","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"2024070101014188400_ref47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2017.11.016","article-title":"Interleukin 6 inhibits the differentiation of rat stem Leydig cells","volume":"472","author":"Wang","year":"2018  5","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2024070101014188400_ref48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mehy.2006.07.002","article-title":"Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer\u2019s disease","volume":"68","author":"Ozen","year":"2007","journal-title":"Med Hypotheses"},{"issue":"11","key":"2024070101014188400_ref49","doi-asserted-by":"crossref","first-page":"e1002960","DOI":"10.1371\/journal.pmed.1002960","article-title":"Testosterone replacement in young male cancer survivors: a 6-month double-blind randomised placebo-controlled trial","volume":"16","author":"Walsh","year":"2019","journal-title":"PLoS Med"},{"issue":"3","key":"2024070101014188400_ref50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/13685538.2015.1034687","article-title":"Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus\u2014a series of case reports","volume":"18","author":"Saad","year":"2015","journal-title":"Aging Male"},{"issue":"5","key":"2024070101014188400_ref51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1530\/EJE-06-0737","article-title":"The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes","volume":"156","author":"Kapoor","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024070101014188400_ref52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0029-1202774","article-title":"Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate","volume":"118","author":"Haider","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2024070101014188400_ref53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/HMBCI.2010.002","article-title":"Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein","volume":"1","author":"Haider","year":"2010","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"2","key":"2024070101014188400_ref54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13685538.2018.1482487","article-title":"The relationship between circulating testosterone and inflammatory cytokines in men","volume":"22","author":"Mohamad","year":"2019","journal-title":"Aging Male"},{"issue":"8","key":"2024070101014188400_ref55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/hrt.2003.021121","article-title":"Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life","volume":"90","author":"Malkin","year":"2004","journal-title":"Heart"},{"issue":"7","key":"2024070101014188400_ref56","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"Malkin","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/12\/3\/449\/58334942\/qeae017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/12\/3\/449\/58334942\/qeae017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:02:38Z","timestamp":1719795758000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/12\/3\/449\/7633160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,21]]},"published-print":{"date-parts":[[2024,6,26]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeae017","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,3,21]]}}}